Responses
Poster Presentations
Psoriatic arthritis
FRI0487 Apremilast is associated with long-term (4-YEAR) DAS-28 (CRP) remission and improvements in skin disease: results from a phase iii study in dmard/biologic-experienced patients with active psoriatic arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.